关于回购股份事项前十大股东和前十大无限售条件股东 持股情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 国泰新点软件股份有限公司（以下简称"公司"）于 2025 年 9 月 24 日召开 第二届董事会第二十次会议，审议通过了《关于以集中竞价交易方式回购股份方 案的议案》，并于 2025 年 9 月 25 日在上海证券交易所网站（www.sse.com.cn） 披露了《新点软件关于以集中竞价交易方式回购股份的预案》（公告编号： 2025-039）。 根据《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关 规定，现将公司第二届董事会第二十次会议决议公告的前一个交易日（即 2025 年 9 月 24 日）登记在册的前十大股东和前十大无限售条件股东的名称、持股数 量和持股比例情况公告如下： 证券代码：688232 证券简称：新点软件 公告编号：2025-044 国泰新点软件股份有限公司 一、公司前十大股东持股情况 二、公司前十大无限售条件股东持股情况 公司股份全部为无限售条件流通股，因此前十大无限售条件股 ...

证券代码：688232 证券简称：新点软件 国泰新点软件股份有限公司 2025年第三次临时股东会 会 议 资 料 2025 年 9 月 国泰新点软件股份有限公司 2025 年第三次临时股东会会议资料 目 录 | 2025 年第三次临时股东会会议须知 | 2 | | --- | --- | | 2025 年第三次临时股东会会议议程 | 4 | | 议案一：关于变更回购股份用途并注销暨减少注册资本的议案 | 6 | | 议案二：关于变更公司注册资本及修订《公司章程》的议案 | 7 | 1 国泰新点软件股份有限公司 2025 年第三次临时股东会会议资料 国泰新点软件股份有限公司 2025 年第三次临时股东会会议须知 为维护国泰新点软件股份有限公司（以下简称"公司"）全体股东的合法 权益，确保股东会的正常秩序和议事效率，保证大会的顺利进行，根据《中华 人民共和国公司法》《中华人民共和国证券法》《上市公司股东会规则》以及 《国泰新点软件股份有限公司章程》（以下简称"《公司章程》"）、《国泰 新点软件股份有限公司股东会议事规则》等相关规定，制定本须知： 一、各股东请按照本次股东会会议通知详见刊登于上海证券交易所网站 （w ...

从近年业绩表现看，2022年-2024年，新点软件业绩波动明显，分别实现营收28.24亿元、24.41亿元、 21.46亿元；分别实现净利润5.73亿元、1.95亿元、2.04亿元。 2025年上半年，公司业绩短期承压，营收与利润出现阶段性下滑。报告期内实现营收6.7亿元，同比下 降14.57%；净利润亏损6218万元，同比下降162.73%，主要受项目验收进度放缓影响。盈利能力方面， 上半年毛利率为59.77%，虽同比下降2.61个百分点，但仍保持较高水平。 长江商报奔腾新闻记者 张璐 新点软件筹划(688232.SH)回购股份，以增强投资者信心。 9月24日，新点软件公告，公司拟以集中竞价交易方式回购股份。回购金额不低于3000万元且不超过 5000万元；回购价格不超42元/股。资金来源为自有资金，回购期限为12个月内。 根据公告，截至2025年6月30日（未经审计），新点软件总资产为63.1亿元，归属于上市公司股东的净 资产为53.44亿元，流动资产为51.59亿元。按照本次回购资金上限5000万元测算，分别占上述指标的 0.79%、0.94%、0.97%。 对于此次股份回购的目的，新点软件表示，基于对 ...

Group 1 - The core viewpoint of the news is that Xindian Software has experienced fluctuations in stock performance and financial metrics, indicating potential investment opportunities and challenges [1][2]. Group 2 - On September 25, Xindian Software's stock rose by 3.24%, with a trading volume of 139 million yuan. The margin trading data shows a net buying of 6.51 million yuan on that day [1]. - As of September 25, the total margin trading balance for Xindian Software is 173 million yuan, which accounts for 1.87% of its market capitalization, indicating a high level of margin activity compared to the past year [1]. - The company repaid 6,300 shares in short selling on September 25, with no shares sold, resulting in a short selling balance of 44,190 yuan, which is low compared to the past year [1]. Group 3 - As of June 30, the number of shareholders for Xindian Software is 8,679, a decrease of 14.87% from the previous period, while the average circulating shares per person increased by 123.45% to 38,022 shares [2]. - For the first half of 2025, Xindian Software reported a revenue of 670 million yuan, a year-on-year decrease of 14.57%, and a net profit attributable to shareholders of -62.18 million yuan, a significant decline of 162.73% [2]. - Since its A-share listing, Xindian Software has distributed a total of 597 million yuan in dividends, with 432 million yuan distributed over the past three years [2]. Group 4 - As of June 30, 2025, among the top ten circulating shareholders, Zhonggeng Value Pioneer Stock holds 11.65 million shares, an increase of 3.02 million shares from the previous period, while Zhonggeng Small Cap Value Stock holds 4.63 million shares, an increase of 1.60 million shares [2].

Core Viewpoint - The company, New Point Software (688232.SH), has decided to adjust the use of its repurchased shares from employee stock incentive plans to cancellation, reducing its total share capital and registered capital accordingly [1] Group 1: Share Repurchase and Capital Adjustment - The company will cancel 8,018,025 shares originally intended for employee stock incentives, leading to a reduction in total shares from 330 million to 322 million [1] - Following the cancellation, the registered capital will decrease from 330 million yuan to 322 million yuan [1] Group 2: Shareholder Structure and Government Actions - The Jiangsu provincial government plans to transfer 100% equity of Jiangsu Guotai International Trade Co., Ltd. to Zhangjiagang City State-owned Assets Management Center, which is a state-owned company funded by the government [1] - The largest shareholder of the company remains unchanged, with the shareholding number and percentage held by the international trade entity remaining the same [1] Group 3: Dividend Policy - The company has maintained a stable dividend policy, with total cash dividends of 198 million yuan, 118 million yuan, and 116 million yuan from 2022 to 2024, totaling 432 million yuan over three years [1] - Based on an average net profit of 324 million yuan over the last three accounting years, the cash dividend ratio reached 133.21% [1]

Group 1 - The core viewpoint of the news is the performance and market position of New Point Software, which saw a stock price increase of 5.48% to 28.66 CNY per share, with a total market capitalization of 9.458 billion CNY [1] - New Point Software's main business segments include Smart Procurement (51.04% of revenue), Smart Government (29.39%), Digital Construction (18.81%), and Rental Income (0.76%) [1] - The company is located in Zhangjiagang Economic Development Zone, Jiangsu Province, and was established on October 6, 1998, with its listing date on November 17, 2021 [1] Group 2 - According to data, Qianhai Kaiyuan Fund holds New Point Software as its tenth largest position in the Qianhai Kaiyuan Event-Driven Mixed A Fund, with 73,800 shares, accounting for 3.69% of the fund's net value [2] - The fund has achieved a year-to-date return of 17.93% and a one-year return of 21.98%, ranking 4816 out of 8173 and 5584 out of 8003 in its category, respectively [2] - The fund manager, Wang Da, has been in position for 2 years and 201 days, with the best and worst fund returns during his tenure being 15.82% and 15.54%, respectively [2]

Key Points - Huasoft Technology is currently producing and selling light initiator products in small batches based on customer orders [1] - Kaineng Health plans to establish a wholly-owned subsidiary in Hainan or Hunan provinces to engage in the cell industry and related mergers and acquisitions [1] - Linyang Energy has won a bid for a 142 million yuan project with the State Grid [1] - New Zhizhi Software intends to acquire 49% equity of Shenzhen Hengdao for 48.2356 million yuan [1] - Xindian Software plans to repurchase shares worth between 30 million to 50 million yuan [1] - Shanjin International has submitted an application for the issuance and listing of H-shares on the Hong Kong Stock Exchange [1] - Zhongwei Semiconductor has also submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [1] - Huadong Heavy Machinery's Wu Qingming Yu No. 6 and Tianchen Jinting No. 1 plan to reduce their holdings by no more than 1.5% [2] - Xinde New Materials' Shang Rong Baoying and its concerted parties plan to reduce their holdings by no more than 3% [2] - Huayi Pharmaceutical's shareholder Wang Xiaopeng plans to reduce his holdings by no more than 12.708 million shares [2] - International Industry plans to raise no more than 660 million yuan through a private placement to its controlling shareholder [2] - Ruima Precision has been awarded a project for automotive air suspension system products [2] - Wanhui High-tech expects a net profit increase of 69.81% to 109.77% for the first three quarters [2]

证券日报网讯 9月24日晚间，新点软件发布公告称，公司拟使用自有资金通过上海证券交易所以集中竞 价交易方式回购公司已发行的部分人民币普通股（A股）股票。回购股份金额不低于人民币3，000.00万 元（含），不超过人民币5，000.00万元（含）。 （编辑 姚尧） ...

Group 1 - Shanghai Zhiyuan Hengyue plans to acquire 37% of the shares of Shangwei New Materials at a price of 7.78 yuan per share, requiring a maximum total funding of 1.16 billion yuan [1] - The acquisition period is set for 30 calendar days, from September 29, 2025, to October 28, 2025 [1] - Zhiyuan Hengyue and Zhiyuan Xinchuan intend to acquire at least 63.62% and up to 66.99% of Shangwei New Materials' shares [2] Group 2 - Heng Rui Pharmaceutical has signed a licensing agreement for the innovative drug SHRA1811, receiving an upfront payment of 18 million dollars and is eligible for up to 1.093 billion dollars in milestone payments [3] - The agreement aims to expand the overseas market for SHRA1811 and enhance the company's innovative brand and overseas performance [3] Group 3 - Tian Shili's subsidiary has received approval for clinical trials of TSL2109 capsules, a dual-target small molecule inhibitor for advanced solid tumors, with no similar drugs currently in clinical trials [4] - The cumulative R&D investment in TSL2109 capsules by Jiangsu Diyi has reached 24.6251 million yuan [4] Group 4 - Wanhui High-tech expects a net profit of 340 million to 420 million yuan for the first three quarters, representing a year-on-year growth of 69.81% to 109.77% [5]

证券日报网讯 9月24日晚间，新点软件发布公告称，公司于2025年9月24日召开第二届董事会第二十次 会议，审议通过了《关于变更回购股份用途并注销暨减少注册资本的议案》，同意对回购专用证券账户 中的回购股份8，018，025股的用途进行调整，由"用于股权激励及/或员工持股计划"变更为"用于注销 并相应减少注册资本"。 （编辑 楚丽君） ...